Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2010-12-31
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NCT02119273
Pre-operative Steroids in CRSsP
NCT05095961
Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps
NCT02927834
Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study
NCT00841802
Effect of Postoperative Additive Systemic Steroids in CRSwNP
NCT04915456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic rhinosinusitis
oral corticosteroid taper
This is an observational study in which patients self-select oral steroid treatment for symptoms of CRS. Drug treatments are NOT assigned in this investigation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral corticosteroid taper
This is an observational study in which patients self-select oral steroid treatment for symptoms of CRS. Drug treatments are NOT assigned in this investigation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CRS defined by 2007 Adult Sinusitis Guidelines.12
* Subject must be able to complete QoL questionnaires written in English
* Previous sinus surgery including unilateral or bilateral total ethmoidectomy
* Minimum nasal blockage score on SinoNasal Outcomes Test-22 (SNOT-22) \> 3
* Severe sinonasal inflammation where the next treatment option is a 12- day oral prednisone taper
* Obstruction of the ethmoid sinus region or middle meatus eligible for revision endoscopic sinus surgery
* Lund-Kennedy endoscopy score \> 4
* Elects 12-day tapering dose of oral steroids (Prednisone) as a next treatment option
Exclusion Criteria
* Contra-indication to oral steroids
* Endoscopic sinus surgery \< 3 months of presentation
* Completed course of oral corticosteroids within the previous 3 month period
* Subjects presenting with unilateral chronic rhinosinusitis
* Pregnancy or possibility to become pregnant during the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oregon Health & Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
unfunded2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.